Tirzepatide is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist used for chronic weight management, along with a reduced calorie diet and increased physical activity, for people with an initial body mass index (BMI) of: 30 kg/m2 or greater (obesity) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, dyslipidemia, obstructive sleep apnea or cardiovascular disease)
However, previous studies on the extent of drug absorption (area under the curve [AUC]) in patients with other gastrointestinal motility disorders reported conflicting results [8, 9]
Bekijk vacature Gouda Interim Administrateur Gouda Financile administratie, facturatie, financile rapportages in Exact Globe en Afas Bekijk vacature Waddinxveen Finance Manager Taken en verantwoordelijkheden Specialist Finance Manager: Het verzorgen van de maandelijkse aangifte BTW
Verdict: For brand-name products, not a concern